Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure

Journal of Laboratory and Clinical Medicine - Tập 136 - Trang 320-327 - 2000
Mary C. Perianayagam1, Sandra L. Murray1, V.S. Balakrishnan1, Daqing Guo1, Andrew J. King1, Brian J.G. Pereira1, Bertrand L. Jaber1
1Division of Nephrology, Tupper Research Institute, Department of Medicine, New England Medical Center. Boston, Massachusetts

Tài liệu tham khảo

Carson, 1993, Apoptosis and disease, Lancet, 341, 1251, 10.1016/0140-6736(93)91154-E Squier, 1995, Apoptosis in leukocytes, J Leukoc Biol, 57, 2, 10.1002/jlb.57.1.2 Rowan, 1997, Mechanisms of apoptotic cell death, Leukemia, 11, 457, 10.1038/sj.leu.2400626 Oehm, 1992, Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily, J Biol Chem, 267, 10709, 10.1016/S0021-9258(19)50076-X Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5 Debatin, 1993, APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia, Blood, 81, 2972, 10.1182/blood.V81.11.2972.2972 Liles, 1996, Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils, J Exp Med, 184, 429, 10.1084/jem.184.2.429 Hsieh, 1997, The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils, Biochem Biophys Res Commun, 233, 700, 10.1006/bbrc.1997.6529 Cheng, 1994, Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science, 263, 1759, 10.1126/science.7510905 Cascino, 1995, Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing, J Immunol, 154, 2706, 10.4049/jimmunol.154.6.2706 Owen-Schaub, 1995, Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?, Cancer Lett, 94, 1, 10.1016/0304-3835(95)03834-J Suda, 1995, Expression of the Fas ligand in cells of T cell lineage, J Immunol, 154, 3806, 10.4049/jimmunol.154.8.3806 Mincheff, 1998, Fas and Fas ligand expression on human peripheral blood leukocytes, Vox Sang, 74, 113, 10.1046/j.1423-0410.1998.7420113.x Lee, 1999, The Fas system, a regulator of testicular germ cell apoptosis, is differentially up-regulated in Sertoli cell versus germ cell injury of the testis, Endocrinology, 140, 852, 10.1210/en.140.2.852 Kayagaki, 1995, Metalloproteinase-mediated release of human Fas ligand, J Exp Med, 182, 1777, 10.1084/jem.182.6.1777 Tanaka, 1996, Fas ligand in human serum, Nat Med, 2, 317, 10.1038/nm0396-317 Schneider, 1998, Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity, J Exp Med, 187, 1205, 10.1084/jem.187.8.1205 Knipping, 1995, Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias, Blood, 85, 1562, 10.1182/blood.V85.6.1562.bloodjournal8561562 Mizutani, 1998, Prognostic significance of soluble Fas in the serum of patients with bladder cancer, J Urol, 160, 571, 10.1016/S0022-5347(01)62960-4 Kawakami, 1998, Increased circulating soluble form of Fas in patients with dilated cardiomyopathy, Jpn Circ J, 62, 873, 10.1253/jcj.62.873 Yamaguchi, 1999, Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure, Am J Cardiol, 83, 1500, 10.1016/S0002-9149(99)00133-2 Matsumoto, 1995, Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure, Biochem Biophys Res Commun, 215, 98, 10.1006/bbrc.1995.2438 Heidenreich, 1996, Apoptosis of monocytes cultured from long-term hemodialysis patients, Kidney Int, 49, 792, 10.1038/ki.1996.110 Cendoroglo, 1999, Neutrophil apoptosis and dysfunction in uremia, J Am Soc Nephrol, 10, 93, 10.1681/ASN.V10193 Jaber, 1999, Neutrophil apoptosis in chronic renal failure (CRF): role of the Fas/Fas ligand (FasL) pathway, J Am Soc Nephrol, 10, 513A Jaber, 1998, Apoptosis-inducing activity of uremic plasma during hemodialysis, Blood Purif, 16, 325, 10.1159/000014352 Bland, 1995, Microbiological and endotoxin considerations in hemodialyzer reprocessing, vol 3, 293 Metcalf, 1986 Kiener, 1997, Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages, J Exp Med, 185, 1511, 10.1084/jem.185.8.1511 Seishima, 1996, Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly, Clin Chem, 42, 1911, 10.1093/clinchem/42.12.1911